c/hamilton-morris
The Hamilton Morris Podcast is a series focused on the chemistry, history, and cultural impact of psychoactive substances
…out of a person, a drug manufacturer, and that's what they're doing. And for example, Medea takes her drug that she uses on Jason from her right um there's a reason that we have the orgasm and the singing right there's a reason because the human body…
…ThatChemist is his name. His name is Josiah, but ThatChemist is his handle. I think I first found out about his videos because Jason is a big fan. And we sometimes talk about them in the lab. And they're very funny because he makes these enormous…
…oh, it's, you know, it's all it's not as bad as people think it is. Or I've seen some people like, for example, Jason, this chemist that I work with, he, he's pretty concerned and goes through periods where he, you know, won't eat food that's touched…
…favorite drug in the sense that I enjoy it recreationally. The reason is that I've spent about 13 years studying DIPT with Jason and None of this research has been published. This has been an extremely labor intensive, ongoing labor of love that we have…
…this year that DIPT was going to be placed in Schedule 1, it was utterly shocking. It was utterly horrifying for me. And Jason and I immediately started scrambling to figure out what we could do. And you could say, well, you guys are researchers working…
…huge hassle. It has to be kept in a safe. The door to the lab that has the safe has to be closed all the time. Jason has to keep a log book of every milligram that is moved in and out of the safe. It's a hassle. And scientific research is…
…and out of the safe. It's a hassle. And scientific research is difficult enough without this kind of stupidity interfering with it. So Jason and I started trying to figure out what it was that we could do. I contacted everyone I knew that might have…
…There's actually a really interesting story about that that I'll save for another time. But John Hunter was so generous that he represented Jason and myself pro bono for months. I mean, this was a huge amount of work for everyone. I can't even begin to…
…We were speaking at a psychedelic conference together and we were staying in the same house and I was preparing for my talk with Jason and I really wanted to talk with Dennis McKenna, but we had all this work to do and then somebody said, well, we're…
…do it, the organizer called me and started lecturing me about all that he was saying. Well, I know the work that you and Jason are doing. Honestly, I think it's the least bad of what Compass is doing at the moment. it's like the least bad how about…
…plant itself. And Brian can speak to this greater than I can, but we're seeing that there's various chemotypes of Dr. Jason Lepojarvii, Ph.D.: Mitragynospesiosis so there's very analogous to what we see with cannabis sativa where you have higher levels of.…
…Mitragynospesiosis so there's very analogous to what we see with cannabis sativa where you have higher levels of. Dr. Jason Lepojarvii, Ph.D.: Mitragynin in some of these Mitragynospesiosis of plants and maybe non-existent levels of Mitragynin which is supposed…
…in some of these Mitragynospesiosis of plants and maybe non-existent levels of Mitragynin which is supposed to be the major. Dr. Jason Lepojarvii, Ph.D.: alkaloid and, in some cases, we see it hardly there at all, so the analogy to the cannabis world…
…they are heading down a path that might be problematic. I remember at a conference in New York years ago, I was talking with Jason and he some neuroscience student came up to us and he said, you've never met me before, but this isn't the last time…
…dose of DPT, which shows a kind of textbook head twitch response. That will allow people to visualize exactly what it is that Jason and I are talking about. And I'm going to attach a few papers as well that will contextualize some of the information…
…to me. And there were other encouraging things that happened during these proceedings. We weren't alone. It wasn't just Jason, myself, and John Hunter. There were many other... extremely passionate lawyers who were working on this simultaneously. And this…
…the prohibition of these substances, as was Mindstate, represented by Tom Ray and, again, Matt Zorn. Panacea also was working and Jason and I were working as individuals so we're not working as representatives of any corporate entity in that instance but…
…are signed. DEA is a terrorist organization, hats and shirts. And there was a final filter paper from a legal psychedelic synthesis that Jason and I had done. For anyone that made those orders, They will be delivered, but we're going to also send out a…
…extent, the right to cross examine the evidence of the government. And so because of that, If we needed to establish that you and Jason had standing to be able to to make that challenge. So we we had to talk about the research that you all have done…
…that it was such an old study that was predicating all of this. And that was fairly evident from the beginning. Hamilton, you and Jason had acquired the HHS report from before we even filed. And that was, in fact, an oddity from me that they could be…
…you know, so they can create these insane criteria. And what do you do in that situation? I mean, this is what... John and Jason and I were struggling with. If the rules that they've made are such that almost any drug arbitrarily could be said to be a…
…week we had to do something significant, you know, which. We managed everyone. Everyone did their part. We had you and you and Jason did amazing work. All of the witnesses that we got in touch with did amazing work. But I couldn't help but think that.…
…this? Who is allowed to object and who isn't? Yeah, I mean, we have a very interested person. And I think with you and Jason, it was like absolutely clear kind of on its face that you guys were doing research with the substance. But there was a…
…we were researching. Right, and correct me if I'm wrong, John, but didn't they actually object to us participating and question whether Jason and I were interested parties? They did, but they backed off of that. I think that they were confused in part…
…And so the next step then was to assemble a defense of these substances, which again was a difficult task. I know that Jason and I were scrambling, trying to figure out what would be persuasive to them because they're using such bad evidence to begin…
…bunch of testimony. We put in a chemist who, and I think you guys had to put in a chemist too, was it you or Jason or someone who basically said, the fact that these are analogs doesn't really tell you much of anything. So what like analogs can be…
…or notice. That was certainly one of many things. But we had a fantastic slate of witnesses, you know, with you, Hamilton, Jason, you know, was Adam, what was his last name? Halberstadt. He had fantastic testimony, Dr. Becker. David Nutt, is anyone in the…